KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

New Approaches to Diagnosis and Therapy in Dementia

Life Science Leadership Series: New Approaches to Diagnosis and Therapy in Dementia on 22 March in Windlesham. 

This event will gather a mix of academic and industry speakers to discuss current and new approaches to diagnosis, drug development and therapy in Dementia. It is aimed to anybody with an interest in Dementia whether they have technologies that could apply to the area or just want to know what are the development trends and network with the right people. 

Programme: 

10.00 - Registration and Networking 

10.30 - Introduction to One Nucleus 

10.40 - Mike Hutton, CSO Neuroscience, Eli Lilly 

11.05 - Simon Ridley, Director of research, ARUK 

11.30 – Session 1 – Accelerating Drug Discovery 

DDIs Strategies 
John Skidmore, CSO Cambridge Drug Discovery Institute 
John Davies, CSO Oxford Drug Discovery Institute 
Paul Whiting, CSO London Drug Discovery Institute 
Dementia Consortium 
Dementia Fund 

12.30 - Lunch 

13.45 - Session 2 – Progresses in Diagnosis 

Early Data Generation to Accelerate Drug Development in Dementia 
Prof Simon Lovestone, University of Oxford 

Blood Based Immunoassay for Pre-dementia Diagnosis of Alzheimer´s disease. A New Tool for Successful Clinical Trials 
Erik Christensen, Prediagnostics 

MRI and Biomarkers Developments 
speaker tbc, Ixico 

Companion Diagnostics and Patient Segmentation in the Early Identification of Alzheimer's Dementia’ 
Charlotte Housden, Cambridge Cognition 

Latest Developments in PET Imaging for Neurodegeneration 
Ilan Rabiner, Imanova 

15.15 - Coffee break 

15.45 - Session 3 – Innovative Therapeutic Approaches 

Updates on Amyloid Pathway Research and Therapeutic Developments 
Speaker tbc 

Tau Targeting Antibodies 
Speaker tbc 

Immunotherapy targeting Alzheimer Tau 
Norbert Zilka, AXON Neuroscience 

Targeting Neuroinflammation in AD 
Diego Gomez-Nicola, University of Southampton 

17.15 - Closing Remarks 
One Nucleus / Eli Lilly 

17.20 - Drinks and Networking 

18.30 - Close

Register here